Is Zim Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Zim Corp (ZIMCF) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Zim Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Zim Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Zim Corp?

Muslim investors may consider investing in Zim Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Zim Corp classified as NOT COVERED?

Musaffa determines the Shariah status of Zim Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Zim Corp updated?

The Shariah compliance status of Zim Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Zim Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Zim Corp?

You can check the latest Shariah compliance status of Zim Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Zim Corp. Stock Analysis ZIMCF

United States Information Technology Nano Cap

ZIM Corp. engages in the development and sale of enterprise database software. Through its subsidiary, NuvoBio Corporation, the Company is involved in research and development projects for cancer therapeutics. The firm is developing intellectual property and advancing research and development in the areas of new synthetic drugs and immunotherapies. The firm is funding research and development projects in areas, including implementing unique molecular interaction and analytics using supercomputing technologies to design small peptide drugs that bind to target proteins for cancer therapies and the development of bi-specific immunology therapies for the treatment of kidney cancer. The company is also funding research and development projects in the areas of new peptide-derived inhibitors for therapeutic intervention against various cancer cell lines in the presence or absence of chemo therapeutics to characterize the in vivo effects of promising inhibitors.

Key Statistics of Zim Corp (ZIMCF)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

375.00

P/E Ratio (TTM)

52 Week Range

$0.00$0.00

Market Cap

813.60

Avg. Volume